Taxanes anthracyclines. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Microtubules Heart

Organisms3

Corylus Taxus Streptomyces

Diseases16

Breast Neoplasms Leukemia P388 Neoplasm Metastasis Heart Diseases Neoplasms Leukemia L1210 Precursor Cell Lymphoblastic Leukemia-Lymphoma Alopecia Cardiomyopathies Disease Progression Ovarian Neoplasms Neoplasm Recurrence, Local Neutropenia Lung Neoplasms Leukemia, Myeloid, Acute Pregnancy Complications, Neoplastic

Chemicals and Drugs59

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Taxoids Bridged Compounds Daunorubicin Doxorubicin Aclarubicin Paclitaxel Epothilones Antineoplastic Agents Antineoplastic Agents, Phytogenic Epirubicin Carubicin Idarubicin Vinblastine Antimitotic Agents Razoxane Tubulin Modulators Nogalamycin Deoxycytidine Fluorouracil P-Glycoprotein DNA Topoisomerases, Type II Receptor, erbB-2 Aconitic Acid Vinca Alkaloids Fluorine Compounds Cyclophosphamide Anthraquinones Dexrazoxane Antibodies, Monoclonal, Humanized Mitoxantrone Cardiotoxins Cisplatin Tubulin Platinum Compounds Topoisomerase II Inhibitors Verapamil Noscapine Cytarabine Antimetabolites, Antineoplastic Antibodies, Monoclonal Liposomes Intercalating Agents Etoposide Vincristine Leukotriene C4 Trifluoperazine Phthalic Acids Antigens, Neoplasm Mitomycin Multidrug Resistance-Associated Proteins Calreticulin Receptors, Estrogen Methotrexate Glycosides Tumor Markers, Biological Lactoperoxidase

Analytical, Diagnostic and Therapeutic Techniques and Equipment22

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Drug Administration Schedule Treatment Outcome Salvage Therapy Disease-Free Survival Drug Screening Assays, Antitumor Clinical Trials, Phase III as Topic Infusions, Intravenous Clinical Trials as Topic Neoadjuvant Therapy Survival Analysis Maximum Tolerated Dose Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Survival Rate Clinical Trials, Phase I as Topic Neoplasm Staging Prognosis Combined Modality Therapy Remission Induction Retrospective Studies

Phenomena and Processes15

Drug Resistance, Neoplasm Drug Resistance, Multiple Dose-Response Relationship, Drug Drug Resistance Genes, erbB-2 Maximum Tolerated Dose Apoptosis Cell Survival Drug Synergism Time Factors Molecular Structure Drug Interactions Cell Cycle Cell Death Structure-Activity Relationship

Technology, Industry, Agriculture1

Information Science1

Named Groups1

Health Care10

Treatment Outcome Disease-Free Survival Clinical Trials, Phase III as Topic Clinical Trials as Topic Survival Analysis Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Survival Rate Clinical Trials, Phase I as Topic Retrospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Named Groups Health Care

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Taxoids Bridged Compounds Daunorubicin Doxorubicin Aclarubicin Paclitaxel Breast Neoplasms Epothilones Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Phytogenic Epirubicin Carubicin Idarubicin Drug Resistance, Neoplasm Vinblastine Antimitotic Agents Razoxane Tubulin Modulators Chemotherapy, Adjuvant Nogalamycin Deoxycytidine Corylus Fluorouracil Leukemia P388 Drug Administration Schedule Neoplasm Metastasis Treatment Outcome P-Glycoprotein DNA Topoisomerases, Type II Heart Diseases Taxus Receptor, erbB-2 Aconitic Acid Vinca Alkaloids Salvage Therapy Fluorine Compounds Disease-Free Survival Neoplasms Drug Resistance, Multiple Drug Screening Assays, Antitumor Cyclophosphamide Dose-Response Relationship, Drug Anthraquinones Dexrazoxane Antibodies, Monoclonal, Humanized Cell Line, Tumor Mitoxantrone Cardiotoxins Clinical Trials, Phase III as Topic Infusions, Intravenous Clinical Trials as Topic Cisplatin Tubulin Tumor Cells, Cultured Drug Resistance Platinum Compounds Leukemia L1210 Neoadjuvant Therapy Topoisomerase II Inhibitors Genes, erbB-2 Survival Analysis Maximum Tolerated Dose Precursor Cell Lymphoblastic Leukemia-Lymphoma Microtubules Randomized Controlled Trials as Topic Verapamil Clinical Trials, Phase II as Topic Apoptosis Noscapine Streptomyces Survival Rate Cell Survival Cytarabine Antimetabolites, Antineoplastic Clinical Trials, Phase I as Topic Drug Synergism Antibodies, Monoclonal Liposomes Neoplasm Staging Time Factors Intercalating Agents Etoposide Alopecia Prognosis Molecular Structure Cardiomyopathies Vincristine Heart Disease Progression Ovarian Neoplasms Leukotriene C4 Survivors Combined Modality Therapy Trifluoperazine Drug Interactions Phthalic Acids

No FAQ available that match "taxanes anthracyclines"